Cargando…
B7-H7 is a prognostic biomarker in epithelial ovarian cancer
BACKGROUND: B7-H7 is a newly identified member of the B7 immune checkpoint family, but has not been investigated in epithelial ovarian cancer (EOC). This study aimed to determine the B7-H7 expression profile and its potential clinical significance in EOC. METHODS: A tissue microarray (TMA) containin...
Autores principales: | Fu, Yuanyuan, Ding, Yun, Liu, Juan, Zheng, Xiao, Wei, Wei, Ying, Yaoyu, Wu, Changping, Jiang, Jingting, Ju, Jingfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798714/ https://www.ncbi.nlm.nih.gov/pubmed/35117901 http://dx.doi.org/10.21037/tcr-20-697 |
Ejemplares similares
-
Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients
por: Chen, Lujun, et al.
Publicado: (2016) -
Serum B7-H4 expression is a significant prognostic indicator for patients with gastric cancer
por: Shi, Hongbing, et al.
Publicado: (2014) -
Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2
por: Zhang, Fenghua, et al.
Publicado: (2020) -
Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions
por: Liu, Juan, et al.
Publicado: (2020) -
Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
por: Chen, Lujun, et al.
Publicado: (2018)